Logo image of CLVT

CLARIVATE PLC (CLVT) Stock Fundamental Analysis

NYSE:CLVT - New York Stock Exchange, Inc. - JE00BJJN4441 - Common Stock - Currency: USD

3.86  +0.05 (+1.31%)

After market: 3.89 +0.03 (+0.78%)

Fundamental Rating

3

Overall CLVT gets a fundamental rating of 3 out of 10. We evaluated CLVT against 82 industry peers in the Professional Services industry. CLVT may be in some trouble as it scores bad on both profitability and health. CLVT scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CLVT was profitable.
CLVT had a positive operating cash flow in the past year.
In the past 5 years CLVT always reported negative net income.
In the past 5 years CLVT always reported a positive cash flow from operatings.
CLVT Yearly Net Income VS EBIT VS OCF VS FCFCLVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B -4B

1.2 Ratios

Looking at the Return On Assets, with a value of -3.79%, CLVT is doing worse than 73.17% of the companies in the same industry.
Looking at the Return On Equity, with a value of -8.68%, CLVT is doing worse than 71.95% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 1.67%, CLVT is doing worse than 67.07% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CLVT is significantly below the industry average of 12.49%.
Industry RankSector Rank
ROA -3.79%
ROE -8.68%
ROIC 1.67%
ROA(3y)-14.17%
ROA(5y)-9.23%
ROE(3y)-29.57%
ROE(5y)-18.95%
ROIC(3y)1.87%
ROIC(5y)1.34%
CLVT Yearly ROA, ROE, ROICCLVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

With a decent Operating Margin value of 8.41%, CLVT is doing good in the industry, outperforming 68.29% of the companies in the same industry.
CLVT's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 66.07%, CLVT belongs to the top of the industry, outperforming 80.49% of the companies in the same industry.
CLVT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.41%
PM (TTM) N/A
GM 66.07%
OM growth 3Y19.56%
OM growth 5Y51.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y0.48%
CLVT Yearly Profit, Operating, Gross MarginsCLVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CLVT is destroying value.
CLVT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CLVT has more shares outstanding
CLVT has a worse debt/assets ratio than last year.
CLVT Yearly Shares OutstandingCLVT Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
CLVT Yearly Total Debt VS Total AssetsCLVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

Based on the Altman-Z score of -0.41, we must say that CLVT is in the distress zone and has some risk of bankruptcy.
CLVT has a worse Altman-Z score (-0.41) than 81.71% of its industry peers.
CLVT has a debt to FCF ratio of 13.65. This is a negative value and a sign of low solvency as CLVT would need 13.65 years to pay back of all of its debts.
CLVT has a worse Debt to FCF ratio (13.65) than 60.98% of its industry peers.
A Debt/Equity ratio of 0.90 indicates that CLVT is somewhat dependend on debt financing.
CLVT has a Debt to Equity ratio of 0.90. This is in the lower half of the industry: CLVT underperforms 68.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 13.65
Altman-Z -0.41
ROIC/WACC0.24
WACC7.08%
CLVT Yearly LT Debt VS Equity VS FCFCLVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

CLVT has a Current Ratio of 0.91. This is a bad value and indicates that CLVT is not financially healthy enough and could expect problems in meeting its short term obligations.
CLVT's Current ratio of 0.91 is on the low side compared to the rest of the industry. CLVT is outperformed by 79.27% of its industry peers.
A Quick Ratio of 0.91 indicates that CLVT may have some problems paying its short term obligations.
CLVT has a worse Quick ratio (0.91) than 79.27% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.91
CLVT Yearly Current Assets VS Current LiabilitesCLVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

CLVT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.69%.
Measured over the past 5 years, CLVT shows a small growth in Earnings Per Share. The EPS has been growing by 1.87% on average per year.
CLVT shows a decrease in Revenue. In the last year, the revenue decreased by -3.92%.
Measured over the past years, CLVT shows a very strong growth in Revenue. The Revenue has been growing by 21.28% on average per year.
EPS 1Y (TTM)-7.69%
EPS 3Y1.87%
EPS 5YN/A
EPS Q2Q%-10%
Revenue 1Y (TTM)-3.92%
Revenue growth 3Y10.85%
Revenue growth 5Y21.28%
Sales Q2Q%-4.44%

3.2 Future

Based on estimates for the next years, CLVT will show a small growth in Earnings Per Share. The EPS will grow by 0.12% on average per year.
CLVT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.76% yearly.
EPS Next Y-10.74%
EPS Next 2Y-2.59%
EPS Next 3Y2.08%
EPS Next 5Y0.12%
Revenue Next Year-7.52%
Revenue Next 2Y-3.74%
Revenue Next 3Y-1.56%
Revenue Next 5Y0.76%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLVT Yearly Revenue VS EstimatesCLVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
CLVT Yearly EPS VS EstimatesCLVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.2 0.4 0.6 0.8

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.36, the valuation of CLVT can be described as very cheap.
CLVT's Price/Earnings ratio is rather cheap when compared to the industry. CLVT is cheaper than 96.34% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.48. CLVT is valued rather cheaply when compared to this.
The Price/Forward Earnings ratio is 5.50, which indicates a rather cheap valuation of CLVT.
96.34% of the companies in the same industry are more expensive than CLVT, based on the Price/Forward Earnings ratio.
CLVT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.04.
Industry RankSector Rank
PE 5.36
Fwd PE 5.5
CLVT Price Earnings VS Forward Price EarningsCLVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLVT is valued cheaply inside the industry as 84.15% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CLVT is valued cheaper than 90.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.96
EV/EBITDA 7.1
CLVT Per share dataCLVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.59%
EPS Next 3Y2.08%

0

5. Dividend

5.1 Amount

No dividends for CLVT!.
Industry RankSector Rank
Dividend Yield N/A

CLARIVATE PLC

NYSE:CLVT (8/8/2025, 8:26:26 PM)

After market: 3.89 +0.03 (+0.78%)

3.86

+0.05 (+1.31%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)11-04 2025-11-04/bmo
Inst Owners62.53%
Inst Owner ChangeN/A
Ins Owners0.83%
Ins Owner Change13.05%
Market Cap2.64B
Analysts74.67
Price Target5.2 (34.72%)
Short Float %10.7%
Short Ratio7.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.04%
Min EPS beat(2)1.75%
Max EPS beat(2)18.32%
EPS beat(4)4
Avg EPS beat(4)5.47%
Min EPS beat(4)0.21%
Max EPS beat(4)18.32%
EPS beat(8)7
Avg EPS beat(8)6.13%
EPS beat(12)11
Avg EPS beat(12)8.6%
EPS beat(16)15
Avg EPS beat(16)8.34%
Revenue beat(2)2
Avg Revenue beat(2)2.7%
Min Revenue beat(2)2.04%
Max Revenue beat(2)3.36%
Revenue beat(4)2
Avg Revenue beat(4)-0.24%
Min Revenue beat(4)-4.81%
Max Revenue beat(4)3.36%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.83%
Revenue beat(16)4
Avg Revenue beat(16)-1.28%
PT rev (1m)0%
PT rev (3m)-5.06%
EPS NQ rev (1m)-1.36%
EPS NQ rev (3m)-4.72%
EPS NY rev (1m)0%
EPS NY rev (3m)1.15%
Revenue NQ rev (1m)0.83%
Revenue NQ rev (3m)-0.62%
Revenue NY rev (1m)0.29%
Revenue NY rev (3m)0.67%
Valuation
Industry RankSector Rank
PE 5.36
Fwd PE 5.5
P/S 1.05
P/FCF 7.96
P/OCF 4.17
P/B 0.53
P/tB N/A
EV/EBITDA 7.1
EPS(TTM)0.72
EY18.65%
EPS(NY)0.7
Fwd EY18.19%
FCF(TTM)0.48
FCFY12.56%
OCF(TTM)0.92
OCFY23.96%
SpS3.66
BVpS7.31
TBVpS-7.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.79%
ROE -8.68%
ROCE 2.12%
ROIC 1.67%
ROICexc 1.74%
ROICexgc N/A
OM 8.41%
PM (TTM) N/A
GM 66.07%
FCFM 13.24%
ROA(3y)-14.17%
ROA(5y)-9.23%
ROE(3y)-29.57%
ROE(5y)-18.95%
ROIC(3y)1.87%
ROIC(5y)1.34%
ROICexc(3y)1.93%
ROICexc(5y)1.38%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.36%
ROCE(5y)1.69%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y62.12%
ROICexc growth 5Y45.61%
OM growth 3Y19.56%
OM growth 5Y51.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y0.48%
F-Score6
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 13.65
Debt/EBITDA 4.76
Cap/Depr 40.65%
Cap/Sales 12.02%
Interest Coverage 250
Cash Conversion 66.51%
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.91
Altman-Z -0.41
F-Score6
WACC7.08%
ROIC/WACC0.24
Cap/Depr(3y)37.07%
Cap/Depr(5y)34.15%
Cap/Sales(3y)10.18%
Cap/Sales(5y)9.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.69%
EPS 3Y1.87%
EPS 5YN/A
EPS Q2Q%-10%
EPS Next Y-10.74%
EPS Next 2Y-2.59%
EPS Next 3Y2.08%
EPS Next 5Y0.12%
Revenue 1Y (TTM)-3.92%
Revenue growth 3Y10.85%
Revenue growth 5Y21.28%
Sales Q2Q%-4.44%
Revenue Next Year-7.52%
Revenue Next 2Y-3.74%
Revenue Next 3Y-1.56%
Revenue Next 5Y0.76%
EBIT growth 1Y-19.21%
EBIT growth 3Y32.53%
EBIT growth 5Y83.55%
EBIT Next Year9479.49%
EBIT Next 3Y362.47%
EBIT Next 5Y154.38%
FCF growth 1Y-31.45%
FCF growth 3Y16.61%
FCF growth 5Y48.48%
OCF growth 1Y-14.01%
OCF growth 3Y25.93%
OCF growth 5Y40.62%